Bemote Side Effects
Generic name: dicyclomine
Medically reviewed by Drugs.com. Last updated on Jun 21, 2022.
Note: This document contains side effect information about dicyclomine. Some dosage forms listed on this page may not apply to the brand name Bemote.
Applies to dicyclomine: oral capsules and tablets, oral solution, parenteral injection.
Side effects include:
Most adverse effects are manifestations of pharmacologic effects at muscarinic-cholinergic receptors and usually are reversible when therapy is discontinued.
Severity and frequency of adverse effects are dose related and individual intolerance varies greatly; although adverse effects occasionally may be obviated by a reduction in dosage, this also will likely eliminate potential therapeutic effects. If dosage of ≥80 mg daily cannnot be achieved because of intolerance, discontinue dicyclomine (the active ingredient contained in Bemote)
For Healthcare Professionals
Applies to dicyclomine: compounding powder, intramuscular solution, oral capsule, oral syrup, oral tablet.
-The most serious adverse reactions include cardiovascular and central nervous system symptoms.
Very common (10% or more): Dry mouth (33%), nausea (14%)
Rare (less than 0.1%): Constipation, anorexia
Very common (10% or more): Dizziness (40%)
Common (1% to 10%): Somnolence, nervousness
Rare (less than 0.1%): Sedation, headache
Very common (10% or more): Blurred vision (27%)
Postmarketing reports: Cycloplegia, mydriasis, blurred vision[Ref]
Common (1% to 10%): Asthenia
Frequency not reported: Fatigue
Postmarketing reports: Malaise, fatigue[Ref]
Rare (less than 0.1%): Rash
Postmarketing reports: Suppressed lactation[Ref]
Postmarketing reports: Delirium or symptoms of delirium such as amnesia (or transient global amnesia), nervousness, agitation, confusional state, delusion, disorientation, hallucination (including visual hallucination), and mania, mood (altered and pseudodementia).[Ref]
More about Bemote (dicyclomine)
- Check interactions
- Dosage information
- During pregnancy
- Drug class: anticholinergics/antispasmodics
Related treatment guides
1. Kagan G, Huddlestone L, Wolstencroft P "Comparison of dicyclomine with antacid and without antacid in dyspepsia." J Int Med Res 12 (1984): 174-8
2. "Product Information. Bentyl (dicyclomine)." Aventis Pharmaceuticals (2002):
3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.